Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):316-8. doi: 10.1097/00126334-200107010-00017.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cohort Studies
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Italy
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / pathology
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Prospective Studies
  • Protease Inhibitors / adverse effects*
  • Risk Factors

Substances

  • Protease Inhibitors